Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062

L. S. Wyrwicz; K-W. Lee; E. Van Cutsem; Y-J. Bang; C. S. Fuchs; I. Kudaba; M. Garrido; H. C. Chung; J. Lee; H. R. Castro; J. Chao; Z. A. Wainberg; Z. A. Cao; D. Aurora-Garg; J. Kobie; R. Cristescu; P. Bhagia; S. Shah; J. Tabernero; K. Shitara

doi:10.1016/j.annonc.2020.08.1948

Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062

L. S. Wyrwicz, K-W. Lee, E. Van Cutsem, Y-J. Bang, C. S. Fuchs, I. Kudaba, M. Garrido, H. C. Chung, J. Lee, H. R. Castro, J. Chao, Z. A. Wainberg, Z. A. Cao, D. Aurora-Garg, J. Kobie, R. Cristescu, P. Bhagia, S. Shah, J. Tabernero, K. Shitara

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S907-S908
Journal	Annals of Oncology
Volume	31
Issue number	Suppl.4
DOIs	https://doi.org/10.1016/j.annonc.2020.08.1948
Publication status	Published - Sept 2020
Externally published	Yes
Event	European Society of Medical Oncology (ESMO) Virtual Congress - Virtual Duration: 19 Sept 2020 → 21 Sept 2020 https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2020.08.1948

Cite this

Wyrwicz, L. S., Lee, K.-W., Van Cutsem, E., Bang, Y.-J., Fuchs, C. S., Kudaba, I., Garrido, M., Chung, H. C., Lee, J., Castro, H. R., Chao, J., Wainberg, Z. A., Cao, Z. A., Aurora-Garg, D., Kobie, J., Cristescu, R., Bhagia, P., Shah, S., Tabernero, J., & Shitara, K. (2020). Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062. Annals of Oncology, 31(Suppl.4), S907-S908. https://doi.org/10.1016/j.annonc.2020.08.1948

@article{5345e10b55634cad89599b6730ba7251,

title = "Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062",

author = "Wyrwicz, {L. S.} and K-W. Lee and {Van Cutsem}, E. and Y-J. Bang and Fuchs, {C. S.} and I. Kudaba and M. Garrido and Chung, {H. C.} and J. Lee and Castro, {H. R.} and J. Chao and Wainberg, {Z. A.} and Cao, {Z. A.} and D. Aurora-Garg and J. Kobie and R. Cristescu and P. Bhagia and S. Shah and J. Tabernero and K. Shitara",

year = "2020",

month = sep,

doi = "10.1016/j.annonc.2020.08.1948",

language = "English",

volume = "31",

pages = "S907--S908",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "Suppl.4",

note = "European Society of Medical Oncology (ESMO) Virtual Congress, ESMO 2020 ; Conference date: 19-09-2020 Through 21-09-2020",

url = "https://www.esmo.org/meetings/past-meetings/esmo-virtual-congress-2020",

}

Wyrwicz, LS, Lee, K-W, Van Cutsem, E, Bang, Y-J, Fuchs, CS, Kudaba, I, Garrido, M, Chung, HC, Lee, J, Castro, HR, Chao, J, Wainberg, ZA, Cao, ZA, Aurora-Garg, D, Kobie, J, Cristescu, R, Bhagia, P, Shah, S, Tabernero, J & Shitara, K 2020, 'Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062', Annals of Oncology, vol. 31, no. Suppl.4, pp. S907-S908. https://doi.org/10.1016/j.annonc.2020.08.1948

Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062. / Wyrwicz, L. S.; Lee, K-W.; Van Cutsem, E. et al.
In: Annals of Oncology, Vol. 31, No. Suppl.4, 09.2020, p. S907-S908.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062

AU - Wyrwicz, L. S.

AU - Lee, K-W.

AU - Van Cutsem, E.

AU - Bang, Y-J.

AU - Fuchs, C. S.

AU - Kudaba, I.

AU - Garrido, M.

AU - Chung, H. C.

AU - Lee, J.

AU - Castro, H. R.

AU - Chao, J.

AU - Wainberg, Z. A.

AU - Cao, Z. A.

AU - Aurora-Garg, D.

AU - Kobie, J.

AU - Cristescu, R.

AU - Bhagia, P.

AU - Shah, S.

AU - Tabernero, J.

AU - Shitara, K.

PY - 2020/9

Y1 - 2020/9

U2 - 10.1016/j.annonc.2020.08.1948

DO - 10.1016/j.annonc.2020.08.1948

M3 - Meeting Abstract

SN - 0923-7534

VL - 31

SP - S907-S908

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl.4

T2 - European Society of Medical Oncology (ESMO) Virtual Congress

Y2 - 19 September 2020 through 21 September 2020

ER -

Wyrwicz LS, Lee KW, Van Cutsem E, Bang YJ, Fuchs CS, Kudaba I et al. Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062. Annals of Oncology. 2020 Sept;31(Suppl.4):S907-S908. doi: 10.1016/j.annonc.2020.08.1948